Incidence and risk factors for cancer after liver transplantation

被引:92
作者
Vallejo, GH
Romero, CJ
de Vicente, JC
机构
[1] Univ Complutense Madrid, Sch Dent, Dept Oral Med & Surg, Madrid, Spain
[2] Hosp 12 Octubre, Dept Digest Surg & Abdominal Transplant Organs, E-28041 Madrid, Spain
[3] Univ Hosp Asturias, Dept Oral & Maxillofacial Surg, Oviedo, Spain
关键词
de novo tumors/liver transplantation; de novo tumors/immunosuppression; liver transplantation; de novo tumors/risk factors; de novo tumors/liver transplantation/incidence;
D O I
10.1016/j.critrevonc.2004.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
De novo tumors (DNT) are a serious complication after orthotopic liver transplantation (OLT), showing a higher overall incidence ranging from 4.7% to 15.7% in non-selected series. Skin cancer (SC) is the most frequent malignancy observed, ranging from 6% to 70% of the tumors observed, followed by post-transplant lymphoproliferative disorders (PTLD) (4.3-30%). Different immunosuppressive protocols do not seem to influence DNT appearance. Colon and upper aerodigestive cancer after OLT seems to be more prone to develop when there are associated risk factors, such as primary sclerosing cholangitis (PSC) and alcoholic liver cirrhosis (ALC). Some risk factors, such as age, smoking, alcohol and others seem to play a role in higher risk for malignancy, but the presence of a long-term immunosuppressive state, more than the specific regimen used, is the basis for this higher incidence. Ethnic and demographic factors are also important variables influencing the heterogeneity of the results, especially influencing Kaposi's sarcoma and skin tumors. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:87 / 99
页数:13
相关论文
共 104 条
[1]
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients [J].
Andreoni, M ;
Goletti, D ;
Pezzotti, P ;
Pozzetto, A ;
Monini, P ;
Sarmati, L ;
Farchi, F ;
Tisone, G ;
Piazza, A ;
Pisani, F ;
Angelico, M ;
Leone, P ;
Citterio, F ;
Ensoli, B ;
Rezza, G .
JOURNAL OF INFECTION, 2001, 43 (03) :195-199
[2]
Kaposi's sarcoma in liver transplant recipients: Morphological and clinical description [J].
Aseni, P ;
Vertemati, M ;
Minola, E ;
Arcieri, K ;
Bonacina, E ;
Camozzi, M ;
Osio, C ;
Forti, D .
LIVER TRANSPLANTATION, 2001, 7 (09) :816-823
[3]
The risk of skin cancer in renal transplant recipients in Queensland, Australia [J].
Bavinck, JNB ;
Hardie, DR ;
Green, A ;
Cutmore, S ;
MacNaught, A ;
OSullivan, B ;
Siskind, V ;
VanDerWoude, FJ ;
Hardie, IR .
TRANSPLANTATION, 1996, 61 (05) :715-721
[4]
RELATION BETWEEN SKIN-CANCER AND HLA ANTIGENS IN RENAL-TRANSPLANT RECIPIENTS [J].
BAVINCK, JNB ;
VERMEER, BJ ;
VANDERWOUDE, FJ ;
VANDENBROUCKE, JP ;
SCHREUDER, GMT ;
THOROGOOD, J ;
PERSIJN, GG ;
CLAAS, FHJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12) :843-848
[5]
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines [J].
Beatty, PR ;
Krams, SM ;
Esquivel, CO ;
Martinez, OM .
TRANSPLANTATION, 1998, 65 (09) :1248-1255
[6]
Liver transplantation for alcoholic cirrhosis: Long term follow-up and impact of disease recurrence [J].
Bellamy, COC ;
DiMartini, AM ;
Ruppert, K ;
Jain, A ;
Dodson, F ;
Torbenson, M ;
Starzl, TE ;
Fung, JJ ;
Demetris, AJ .
TRANSPLANTATION, 2001, 72 (04) :619-626
[7]
De novo internal neoplasms after liver transplantation:: Increased risk and aggressive behavior in recent years? [J].
Benlloch, S ;
Berenguer, M ;
Prieto, M ;
Moreno, R ;
San Juan, F ;
Rayón, M ;
Mir, J ;
Segura, A ;
Berenguer, J .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (04) :596-604
[8]
Berenguer M, 1998, MED CLIN-BARCELONA, V111, P481
[9]
Kaposi's sarcoma after liver transplantation [J].
Besnard, V ;
Euvrard, S ;
Kanitakis, J ;
Mion, F ;
Boillot, O ;
Frances, C ;
Faure, M ;
Claudy, A .
DERMATOLOGY, 1996, 193 (02) :100-104
[10]
Bessa X, 1997, Gastroenterol Hepatol, V20, P442